Doctor Anna Moiseeva

The impact of modulation of SNS activity on the evolution of heart failure and exercise capacity in patients with resistant hypertension and heart failure with preserved ejection fraction

Event: Heart Failure 2024

Topic: Devices for Autonomic Modulation

Session: ePosters in chronic heart failure - treatment 7

Access

Like

Comparative evaluation of renal denervation versus pharmacological treatment on diastolic function in patients with resistant hypertension: three years follow-up

Event: ESC Congress 2023

Topic: Device Treatment and Intervention

Session: Drugs and devices in hypertension

Access

Like

Impact of renal denervation treatment on NT-proBNP level and Six-Minute Walk Test in patients with resistant hypertension and heart failure with preserved ejection fraction

Event: Heart Failure 2023

Topic: Devices for Autonomic Modulation

Session: ePosters in chronic heart failure - treatment 3

Access

Like

Long-term antihypertensive effect of renal denervation in resistant hypertension: three years follow-up

Event: ESC Congress 2022

Topic: Device Treatment and Intervention

Session: Hypertension - Treatment from pharmacotherapy to device and intervention

Access

Like

The impact of renal denervation on diastolic function in patients with resistant hypertension and heart failure with preserved ejection fraction: one year follow-up

Event: Heart Failure 2022

Topic: Hypertension, Other

Session: Modern technologies in heart failure

Access

Like

Modulation of sympathetic nervous system activity through various therapeutic approaches in patients with resistant hypertension and heart failure with preserved ejection fraction

Event: ESC Preventive Cardiology 2022

Topic: Multidisciplinary Interventions

Session: ePosters

Access

Like

The effectiveness of renal denervation performed with various types of catheters on blood pressure values in patients with resistant hypertension

Event: Heart Failure 2021

Topic: Hypertension, Other

Session: ePoster session

Access

Like

The impact of renal denervation treatment on left ventricular remodeling in patients with resistant hypertension

Event: ESC Preventive Cardiology 2021

Topic: Device Treatment and Intervention

Session: ePosters

Access

Like

Sympathetic renal denervation treatment in resistant hypertension: one-year follow-up

Event: ESC Congress 2020

Topic: Device Treatment and Intervention

Session: Devices in Hypertension

Access

Like

The effects of long-term treatment with sympathetic nervous system blockers on diastolic function in patients with resistant hypertension and heart failure with preserved ejection fraction

Event: Heart Failure 2019

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Access

Like

Doctor Anna Moiseeva

Contributor content

The impact of modulation of SNS activity on the evolution of heart failure and exercise capacity in patients with resistant hypertension and heart failure with preserved ejection fraction

Comparative evaluation of renal denervation versus pharmacological treatment on diastolic function in patients with resistant hypertension: three years follow-up

Impact of renal denervation treatment on NT-proBNP level and Six-Minute Walk Test in patients with resistant hypertension and heart failure with preserved ejection fraction

Long-term antihypertensive effect of renal denervation in resistant hypertension: three years follow-up

The impact of renal denervation on diastolic function in patients with resistant hypertension and heart failure with preserved ejection fraction: one year follow-up

Modulation of sympathetic nervous system activity through various therapeutic approaches in patients with resistant hypertension and heart failure with preserved ejection fraction

The effectiveness of renal denervation performed with various types of catheters on blood pressure values in patients with resistant hypertension

The impact of renal denervation treatment on left ventricular remodeling in patients with resistant hypertension

Sympathetic renal denervation treatment in resistant hypertension: one-year follow-up

The effects of long-term treatment with sympathetic nervous system blockers on diastolic function in patients with resistant hypertension and heart failure with preserved ejection fraction

ESC 365 is supported by

Doctor Anna Moiseeva Follow

Contributor content

The impact of modulation of SNS activity on the evolution of heart failure and exercise capacity in patients with resistant hypertension and heart failure with preserved ejection fraction

Comparative evaluation of renal denervation versus pharmacological treatment on diastolic function in patients with resistant hypertension: three years follow-up

Impact of renal denervation treatment on NT-proBNP level and Six-Minute Walk Test in patients with resistant hypertension and heart failure with preserved ejection fraction

Long-term antihypertensive effect of renal denervation in resistant hypertension: three years follow-up

The impact of renal denervation on diastolic function in patients with resistant hypertension and heart failure with preserved ejection fraction: one year follow-up

Modulation of sympathetic nervous system activity through various therapeutic approaches in patients with resistant hypertension and heart failure with preserved ejection fraction

The effectiveness of renal denervation performed with various types of catheters on blood pressure values in patients with resistant hypertension

The impact of renal denervation treatment on left ventricular remodeling in patients with resistant hypertension

Sympathetic renal denervation treatment in resistant hypertension: one-year follow-up

The effects of long-term treatment with sympathetic nervous system blockers on diastolic function in patients with resistant hypertension and heart failure with preserved ejection fraction

ESC 365 is supported by

Doctor Anna Moiseeva